Related Experiment Video
Updated: Jun 11, 2025
08:45
Characterizing RNA Modifications in Single Neurons Using Mass Spectrometry
Published on: April 21, 2022
2.3K
RNA m6A modification in ferroptosis: implications for advancing tumor immunotherapy
Jun-Xiao Shi1, Zhi-Chao Zhang1, Hao-Zan Yin2
1The Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, 200438, China.
Molecular Cancer
|September 28, 2024
Summary
This review explores how RNA m6A modification influences ferroptosis, a cell death process crucial for cancer immunity. Understanding this link can improve ferroptosis-sensitive immunotherapy for resistant cancers.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Cancer remains a leading cause of mortality globally, necessitating innovative therapeutic strategies.
- Immunotherapy shows promise but faces challenges with limited response rates and immune resistance.
- Ferroptosis, an iron-dependent cell death, is linked to the tumor immune environment and can overcome treatment resistance.
Purpose of the Study:
- To summarize the regulatory characteristics of RNA m6A modification on ferroptosis.
- To discuss the role of RNA m6A-mediated ferroptosis in tumor cell response to immunotherapy.
- To identify potential targets for enhancing immunotherapy effectiveness in immune-resistant malignancies.
Main Methods:
- Comprehensive literature review of RNA m6A modification, ferroptosis, and immunotherapy.
- Analysis of the interplay between m6A modification, ferroptosis, and immune checkpoints.
- Synthesis of current understanding regarding m6A-mediated ferroptosis in cancer.
Main Results:
- RNA m6A modification regulates cellular susceptibility to ferroptosis.
- Aberrant m6A modification impacts the expression of immune checkpoints.
- Ferroptosis induction is a promising strategy to overcome resistance to conventional cancer treatments.
Conclusions:
- Clarifying m6A modification's regulation of ferroptosis offers a novel approach to cancer therapy.
- Targeting RNA m6A-mediated ferroptosis can enhance the efficacy of immunotherapy for resistant cancers.
- This review provides insights for developing more effective ferroptosis-sensitive immunotherapies.
Related Concept Videos
02:15Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
01:53RNA Stability
33.3K
Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
33.3K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
02:23RNA Editing
8.9K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
8.9K
01:32RNA Splicing
56.1K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.1K